chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Missed second shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second shot) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  The patient's wife called to report that her husband received his first shot on 3March2021 in his left non dominant deltoid. He was due for his second shot on 1April2021 however, on 8March2021 he was admitted to the hospital and just got out of rehab, so he missed his second shot. She states that his admission to the hospital was most likely unrelated to the vaccination and he had no side effects following the first dose. She needs help rescheduling another appointment for him, as the rehab center and the vaccination provider advised her to call Moderna.
Information has been received from a registered nurse concerning a 4 year old male who on 05-JUN-2007 was vaccinated with a dose of ProQuad (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3, Oka/Merck upgrade process).  There was no concomitant medication.  On approximately 05-JUL-2007 the patient developed moderate chicken pox, about 50 lesions on his legs and torso with a high fever.  Unspecified medical attention was sought.  No diagnostic studies or labs were performed.  It was noted that the patient was not recovered.  There was no product quality complaint.  This is one of several reports from the same source.
After first dose of Moderna COVID 19 I noticed a slight ringing in both ears but did not connect it to the vaccine at that time. After receiving the second dose the ringing became more pronounced after about 6 hrs later from vaccine time. It is still happening.
Patient started feeling bad due to fever, nausea, vomiting, and blood in urine. Was transported to emergency room and was diagnosed with sepsis. Was admitted overnight and given iv fluids and antibiotics. Discharged following day and given more antibiotics
Tingly itchy skin within 15 minutes, numb lips, numb finger tips on both hands, tightness in throat
Got the COVID infection after getting the first dose of the COVID Vaccine; This is a spontaneous report from a contactable pharmacist. A male patient of an unspecified age received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: unknown; Expiration Date: unknown), via an unspecified route of administration on 31Dec2020 as SINGLE DOSE for COVID-19 immunization.  The patient medical history was not reported. The patient's concomitant medications were not reported. One week later after the first dose of the vaccine he reported COVID infection. The outcome of the event was unknown.     Information on the Lot/Batch number has been requested.
Pt reports developing a fever and muscle and body aches within 1 day of vaccine administration. Fever lasted from 9/4/09 through 9/9/22/09 when pt's wife called the Health Dept to report the event. This PHN spoke with wife, encouraged her to have pt seek medical attention for a three-week fever, and also called Vaccine Mgt, who stated that three weeks of fever from a vaccine is highly unlikely. Pt was then seen at Health Services, was diagnosed with a viral illness and had blood drawn. He returns to Health Services on 10/2/09 for follow-up. He is a student and has continued to attend school despite ongoing fever.
Patient received Pfizer Covid19 monovalent vaccine instead of the Pfizer Covid19 bivalent booster dose.
I received the vaccine on Tuesday 09/17. Later in the night I started running a fever, and nausea. The next couple of days that followed I was fighting the fever with ibuprofen and Tylenol. My arm started swelling and a lump the size of a baseball formed from fluid build-up and was very painful. I continued to treat this at home up until Saturday when I noticed a small rash on my right arm.  The following Sunday morning the rash had spread and was raised, and scattered. However, the swelling had gone down. The rash was very warm to the touch and holding heat. Later in the day, the rash spread even more. I could not sleep due to the pain in my arm and the rash was hot. I sought treatment at the ER/Urgent care and was diagnosed with Cellulitis.
Approx. 6 hours after vaccine administered, pt developed fever up to 102 and nausea and vomiting. Vomiting occurred after taking ibuprofen. Was prescribed Phenergan 12.5mg. Felt better, then 2 days after vaccine developed stiff neck and urine was brown. Taken to ER by mother, and he was noted to have slightly elevated liver functions. LP, EBV, hepatitis labs, CBC all normal. Lyme and RMSF negative. Continued to have HA, intermittent fever, and fatigue. Liver functions spiked, then started improving prior to discharge. D/C diagnosis was viral illness. CMV IgM neg. IgG positive. 8/25 - Report LFT's normalizing, CMV culture pending.   9/12/08 Reviewed hospital medical records of 8/17-8/21/2008. FINAL DX: febrile illness/viral illness; post lumbar puncture HA; elevated LFTs; mild left renal pelvicaliectasis. Records reveal patient experienced fever, stiff neck & vomiting x 3 days then developed brown urine.  Had questionable tick bites approx 2 weeks prior to admit.  Neuro consult & phone GI consult done.  Referred to outpatient Uro clinic.
Mom describes that within one week of vaccination, the patient developed a rash on her neck and face that both hurt and itched. The rash was described as also being red and swollen and about the size of acne without the pustule. Mom gave the patient Benadryl and the rash went away, but returned as soon as the Benadryl was stopped. The patient underwent testing at her chiropractor who determined that she was exposed to chemicals and needed to be detoxified. She was "chemically detoxified" 3 times, with the rash returning after each treatment. At this time, the chiropractor has this patient taking daily Adrenal Cortex, ADB5, and Bio D as she can no longer have the chemical detoxification treatments and the rash is no longer present with these daily supplements.
about 23OCT97 to 29OCT97 apprehensive, nervous, impending doom no temp, did have h/a, bed very early, sl BP elevation, dizzy when working out, no energy-no appetite;
Flu symptoms. with fever on and off , running nose,cough,.  Dr. prescribed Decadron ,Xyzal,and Zithromax
Chills; stomach pain joints; vomit; weak blood pressure; stomach pain joints; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in right arm at 63-year-old (not pregnant at the time of vaccination) on 03Mar2021 at 16:00 (lot number: EN6198, expiration date unknown) at single dose for COVID-19 immunization. Medical history included diverticulitis. No known allergies were reported. The patient was not diagnosed with COVID prior vaccination. Concomitant medications were reported as unspecified other medications in two weeks. No other vaccine in four weeks. On 04Mar2021 at 06:00 AM the patient experienced chills stomach pain joints vomit weak blood pressure (as reported). The events resulted in hospitalization. The patient underwent lab tests and procedures which included nasal swab: negative on 04Mar2021. No COVID tested post vaccination. It was unknown whether treatment was received. The outcome of the events was not recovered.
chest pain diagnosed as Pericarditis at hospital on Approx May 14, 2021
Pediatric dose was given to adults mistakenly; Moderna COVID-19 vaccine administered to patients post temperature excursion; Poor quality product administered; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered).    Concomitant product use was not provided by the reporter. This case contains information for the patient 98 out 104 patients described by the reporter. It was reported there was a temperature excursion between 26 May 2022 to 30 Sep 2022 and lot AR5186C was affected between 08 Sep 2022 to 27 Sep 2022. AR5186C was previously reported. Pediatric dose was given to adults mistakenly and were reported to Department of Public Health, VAERS, Immunization Registry and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose. 051B22A was kept in the freezer upon receipt of shipment on 01-Aug-2022 and individual vials were put in the refrigerator on the day of use.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-669791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-669791:
Two days after receiving vaccine, I experienced severe rashes covering about one half of lower left leg and considerable edema there and swollen lymph node in left groin and a little less rash and no edema on lower right leg. The rashes are most acute at the sites of dog bites from April, 2020.
Information has been received from a physician concerning a female (age not reported) who on an unspecified date was vaccinated with a 0.5 mL dose of Gardasil.  Immediately following the vaccination, the patient experienced dizziness, nausea and then fainted.  The patient sought unspecified medical attention.  Subsequently, the patient recovered.  This is one of several reports from the same source.  Additional information has been requested.
This case was reported by a consumer via GSK/market research programs and described the occurrence of frequent bowel movements in a infant female patient who received ROTAVIRUS vaccine. On 17th October 2014, the patient received ROTAVIRUS vaccine. On an unknown date, less than a week after receiving ROTAVIRUS vaccine, the patient experienced frequent bowel movements and diaper rash. On an unknown date, the outcome of the frequent bowel movements and diaper rash was unknown. The reporter considered the frequent bowel movements and diaper rash to be possible related to ROTAVIRUS vaccine.
Unable to sleep and restless. Had the vaccine at 11:45 am. It is now 5:00 am the next day, and I am wide awake and jittery. With ringing in my ears and a slight temp.  The main complaint is the inability to sleep.
Narrative:  UNKNOWN CAUSE OF DEATH PER CHART REVIEW; NO DEATH CERTIFICATE FOUND. UNLIKELY CAUSED BY COVID-19 VACCINE; HOWEVER, UNKNOWN.
A portion of my bottom lip has lost it?s color. I woke up the next day after my shot and saw that this part of my lip was extremely light pink and a little raised like it is swollen.   I also have been experiencing eye pain.
mom states pt cried for 6hrs non-stop, area swollen & red where Tetramune was given-pt did not inform facility of this till 4month exam
Pt. recieved vaccine 12 hours past expiration. No adverse event. MD contacted pt. Pt. declined revaccination.
None noted.  Followed up today, 5 days after vaccination.  She only had a mildly sore arm.
Left Leg Swelling and pain  According to MOC, child refuse to bear weight on left leg but has resolved by ER visit on 10/11/2019. Patient walking on their own in hospital fever 100.4 F rectal temperature at hospital  Treatment per hospital discharge: Tylenol or Ibuprofen for pain, follow up pcp within 3-5 days if needed, return for worsening of symptoms 10/15/2019- PCP visit at office Symptoms have since resolved. no edema, induration, or erythema present at PCP visit
Patient contacted pharmacy to report a feeling of "pain in her bones," primarily in her "spine." No other symptoms were reported. I contacted the patient today (2/8/17) and patient was still experiencing the pain, but it has been improving. I instructed her to contact us or her primary care provider if symptoms do not resolve in the next 48 hours or if they worsen.
Started having symptoms day of vaccination (9/30/16) symptoms include left arm swelling, nerve pain that has gotten worse. Pain is radiating front site of injection down to fingers (three center fingers) and up to left lower shoulder. It is severe enough to cause lack of sleep. Site swollen. Came to employee health 10/12/16. Will be followed in Occupational Health.
Hypo-osmolality and hyponatremia Acute kidney failure, unspecified Systemic inflammatory response syndrome (sirs) of non-infectious origin without acute organ dysfunction
Administering vaccine Improperly stored and handled; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (Administering vaccine Improperly stored and handled) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administering vaccine Improperly stored and handled). At the time of the report, PRODUCT STORAGE ERROR (Administering vaccine Improperly stored and handled) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Administered the vaccine used a punctured vial for 24hours and some even more than 24hours.
Fever; swelling status post DTaP Orapred 10mg BID x 3-5d.
Patient lost consciousness/blacked out and fell out of observation chair. Patient suffered a minor head injury including a laceration. 911 was called. Patient became alert and oriented as well as stopped the bleeding before paramedics arrived. After being assessed by the paramedics, he requested not to go to the hospital and to leave on his own. I requested the patient sit for another 15 minutes before leaving to which he obliged and thanked me before leaving.
This case was reported by a consumer via call center representative and described the occurrence of hives in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced hives. On an unknown date, the outcome of the hives was unknown. It was unknown if the reporter considered the hives to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient got hives after the 1st dose. The patient was advised not to get the 2nd dose.
Headache, Sedation, Myalgia, Diarrhea,  NauseaVomiting,  chills, sweating   Narrative:
Extreme pain at the site of vaccine application. The shoulder pain and lack of hand mobility has continued after 3 months with no improvement.
sore, red and hot arm at injection site (lasted 5 days), chills, sweats, low grade fever, fatigue.
8:00 PM on shot day..tired..by 12:00 a.m. temperature of 100.7...and it went up and down throughout the night into the next morning.  Was unable to get off the couch due to tiredness and muscle aches throughout Thursday and Thursday night.  Woke up Friday, feeling better and more productive.  But by Friday night at 7:00 I was back on the couch with a severe headache and dizziness and still felt off on Saturday morning which resulted in a visit to the Walk In to see what was going on.
Fever, nausea, vomiting for 24 hrs. Seems to be improving.
The pt experienced a local reaction to DTaP vaccine. One of three similar reactions reported at this facility in the past two weeks. The pt received the pediatric vaccine instead of the adult vaccine.
Numb left hand.  It came on about an hour after the vaccine and lasted about an hour
Patient had a large bruise and pain at injection site for 2-3 days. On the 3rd day started with itching on the left upper arm and hives on left arm. Took BENADRYL PO and applied BENADRYL cream which helped some but itching and hives some on other body parts but worse L arm have returned -persisted thru today.
Anaphalyxis and angioedema within an hour of the vaccination. I was treated with benadryl and dexamethasone. Due to the vaccine, I have lasting idiopathic angioedema and have to take dexamethasone daily.
Pt received booster MMR for travel on 3/11/13. Started feeling bad on 3/19/13, to doctor on 3/20/13 and 3/22/13. Broke out in full body rash on 3/23/13. Max temp 103. Bld test done to prove measles by doctor.
At 3 am the next day after my vaccine (sat the 9th)I woke up to all my joints burning, like they were on fire. The next morning I had chills, severe joint pain, fatigue, dizziness, nausea, and rash/ redness on my face (cheeks, nose, forehead). The next day (Sunday, the 10th) I felt much better but still a bit of joint pain and fatigue. Today (Monday the 11th) I felt fatigued, with. A resting heart rate of 90 according to my fitbit. I had some numbness/tingling in my right arm, dizziness, and felt fatigued. Towards the end of today I felt better but still have some pain in lower back and neck.
1st vaccine 1997 8-10 pox around injection. 2nd vaccine 9/18/08 20+ pox over body.
first vaccine on 14Feb2021/second dose on 24Feb2021/tested positive for the Covid-19 virus at the end of Aug2021.; first vaccine on 14Feb2021/second dose on 24Feb2021/tested positive for the Covid-19 virus at the end of Aug2021.; had first vaccine on 14Feb2021, states she got the second dose on 24Feb2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group for a Pfizer sponsored program (159558). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administration date 14Feb2021 (Lot number: EL9263) as dose 1, single and administration date 24Feb2021 (Lot number: EL3247) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (ongoing), notes: Verbatim: Asthma, Diagnosed years ago, probably 30 years ago; "Fibromyalgia" (ongoing), notes: Verbatim: Fibromyalgia, Diagnosed years ago, probably 30 years ago. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 27Aug2021, outcome "unknown", COVID-19 (medically significant) with onset 27Aug2021, outcome "recovered" (Sep2021) and all described as "first vaccine on 14Feb2021/second dose on 24Feb2021/tested positive for the Covid-19 virus at the end of Aug2021."; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 24Feb2021, outcome "unknown", described as "had first vaccine on 14Feb2021, states she got the second dose on 24Feb2021". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Aug2021) positive. Therapeutic measures were taken as a result of covid-19.
Complete muscle weakness next morning.  Fell out of bed, could not get up for 45 minutes.  Urinated involuntarily.
your voice with the phone conversation is hurting my ear and the upper part of my head; Banging headache,mostly on half of my face and my eye your /voice with the phone conversation is hurting my ear and the upper part of my head; Feverish, fever; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (your voice with the phone conversation is hurting my ear and the upper part of my head), PYREXIA (Feverish, fever) and HEADACHE (Banging headache,mostly on half of my face and my eye your /voice with the phone conversation is hurting my ear and the upper part of my head) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 01-Nov-2021, the patient experienced PYREXIA (Feverish, fever). On 02-Nov-2021, the patient experienced EAR PAIN (your voice with the phone conversation is hurting my ear and the upper part of my head) and HEADACHE (Banging headache,mostly on half of my face and my eye your /voice with the phone conversation is hurting my ear and the upper part of my head). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Pyrexia, at a dose of 1 dosage form. At the time of the report, EAR PAIN (your voice with the phone conversation is hurting my ear and the upper part of my head), PYREXIA (Feverish, fever) and HEADACHE (Banging headache,mostly on half of my face and my eye your /voice with the phone conversation is hurting my ear and the upper part of my head) outcome was unknown.            No concomitant medications were reported. She is wondering if it would be ok to take an Excedrin instead of another Tylenol
This spontaneous report as received from a other health professional refers to a unspecified number of unknown age. it was reported that unspecified number of patients received improperly stored (Oka/Merck) VARIVAX, on an unspecified day. No adverse effects were reported. This is one of several reports. Additional information has been requested.